T1	Participants 105 149	in patients with haematological malignancies
T2	Participants 395 418	in neutropenic patients
T3	Participants 552 591	Adults with haematological malignancies
T4	Participants 1577 1642	Significantly more patients receiving flu required amphotericin B
